Saltar al contenido
Fuerza y músculoArtículo de investigación3 min read

Sarcopenia in Japanese older adults linked to about twice the risk of death and more disability

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. · Journal of cachexia, sarcopenia and muscle · 2020 · Artículo original ↗

Idea principal

Among 1851 Japanese adults aged 65+, sarcopenia affected 11.5% of men and 16.7% of women, and was linked to higher mortality (HR 2.0 in men, 2.3 in women) over 5.8 years. Low muscle mass alone, without weak grip or slow walking, was not linked to higher risk, but the confidence intervals are wide.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Sarcopenia, the loss of muscle mass and function with age, has been studied less in Asian populations. The authors wanted to know how common it is in community-dwelling older Japanese adults, which factors go with it, and how strongly it and each of its components relate to death and new disability.

Población y método

Prospective cohort of 1851 residents of Japan aged 65 or older (50.5% women; mean age 72.0, SD 5.9) who took part in health check-ups and were followed for 5.8 years. Sarcopenia was defined by the Asian Working Group for Sarcopenia 2019 algorithm, with appendicular lean mass index (ALMI) measured by segmental multi-frequency bioelectrical impedance analysis. Cox proportional hazards models related sarcopenia and combinations of its components to all-cause mortality and incident disability.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Sarcopenia prevalence was 11.5% (105/917) in men and 16.7% (156/934) in women.
  2. 2
    Apart from ageing, sarcopenia was associated with low albumin, cognitive impairment, low activity and recent hospitalization in men (all P < 0.05), and with cognitive impairment (P = 0.004) and depressed mood (P < 0.001) in women.
  3. 3
    People with sarcopenia had higher mortality (hazard ratio 2.0, 95% CI 1.2-3.5 in men; 2.3, 1.1-4.9 in women) and higher risk of incident disability (1.6, 1.0-2.7 in men; 1.7, 1.1-2.7 in women).
  4. 4
    Low grip strength and/or slow gait speed without low ALMI tended toward more disability (1.4, 1.0-2.0, P = 0.087) but not mortality (1.3, 0.8-2.2). Low ALMI alone showed no increased risk of mortality (1.2, 0.8-1.9) or disability (0.9, 0.6-1.3).

Límites e incertidumbre

  1. 1
    Observational design: sarcopenia and the associated factors, such as cognition and mood, may be intertwined with illness that also drives death and disability.
  2. 2
    Some confidence intervals are wide (for example 1.1-4.9 in women) and the component-combination results were not significant, so those subgroup findings are imprecise.
  3. 3
    Muscle mass came from bioelectrical impedance, which is an estimate and can differ from imaging methods, and participants were health check-up attendees in Japan.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

Muscle strength and walking speed look at least as informative for later risk as muscle mass alone in this cohort. That supports paying attention to grip, gait and daily activity as people age, but it does not show that building muscle will lower these risks. Concerns about weakness or falls are worth raising with a clinician.

Tus datos

Home scales with body-composition estimates use impedance, much like the study, but they are rough and vary with hydration, so look at trends on one device. Grip strength and gait speed are better signals here; walking pace and daily steps from a wearable can be tracked, but compare with your own baseline over weeks.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

There is limited evidence on sarcopenia in Asian populations. This study aimed to clarify the prevalence, associated factors, and the magnitude of association with mortality and incident disability for sarcopenia and combinations of its components among Japanese community-dwelling older adults.

Methods

We conducted a 5.8 year prospective study of 1851 Japanese residents aged 65 years or older (50.5% women; mean age 72.0 ± 5.9) who participated in health check-ups. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 algorithm. Appendicular lean mass index (ALMI) was measured using direct segmental multi-frequency bioelectrical impedance analysis. A Cox proportional hazards regression model was used to identify associations of sarcopenia and the combinations of its components with all-cause mortality and incident disability.

Results

The prevalence of sarcopenia was 11.5% (105/917) in men and 16.7% (156/934) in women. Significant sarcopenia-related factors other than ageing were hypoalbuminaemia, cognitive impairment, low activity, and recent hospitalization (all P-values <0.05) among men and cognitive impairment (P = 0.004) and depressed mood (P < 0.001) among women. Individuals with sarcopenia had higher risks of mortality [hazard ratios (95% confidence interval): 2.0 (1.2-3.5) in men and 2.3 (1.1-4.9) in women] and incident disability [1.6 (1.0-2.7) in men and 1.7 (1.1-2.7) in women]. Compared with the individuals without any sarcopenia components, those having low grip strength and/or slow gait speed without low ALMI tended to have an increased risk of disability [1.4 (1.0-2.0), P = 0.087], but not mortality [1.3 (0.8-2.2)]. We did not find increased risks of these outcomes in participants having low ALMI in the absence of low grip strength and slow gait speed [1.2 (0.8-1.9) for mortality and 0.9 (0.6-1.3) for incident disability].

Conclusions

Japanese older men and women meeting Asian criteria of sarcopenia had increased risks of all-cause mortality and disability. There were no significant increased risks of death or incident disability for both participants with muscle weakness and/or low performance without low muscle mass and those with low muscle mass with neither muscle weakness nor low performance. Further studies are needed to examine the interaction between muscle loss, muscle weakness, and low performance for adverse health-related outcomes.

Fuentes y atribución

Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults.

Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H, Nishi M, Taniguchi Y, Narita M, Fujiwara Y, Shinkai S.

Journal of cachexia, sarcopenia and muscle · 2020-11-25

DOI: 10.1002/jcsm.12651 ↗PubMed · 33241660 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Revisión de revisiones

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis observacional

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
Fuerza y músculo →